CD36 and neoplasm: Mechanistically, PLIN2 accelerates CRC progression via a dual mechanism: it induces macrophage reprogramming towards the tumor-promoting M2 phenotype, while simultaneously triggering the CD36-dependent EMT cascade in CRC cells.